2m 2m 2m 2m 2m 2m 2m
DENALI THERAPTCS (DNLI)
NASDAQ
$20.01-$0.53 (-2.56%)
Price as of Oct 02, 2026 5:07 PM EDT- $3.3BMarket Cap
- 35.07%1-Year Change
- BiotechnologyIndustry
DENALI THERAPTCS (DNLI)
$20.01-$0.53 (-2.56%)
DNLI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $20.53 | ||
Change | -$0.14 (-0.68%) | ||
Open | $20.55 | ||
High | $20.85 | ||
Low | $20.40 | ||
Previous Close | $20.67 | ||
Volume | 1,939,762 | ||
30-Day Average Volume | 1,777,562 | ||
1-Week Change | 0.29% | ||
1-Month Change | -11.76% | ||
1-Year Change | 35.07% | ||
3-Year Change | -0.48% | ||
5-Year Change | -59.73% | ||
Fundamentals | |||
Shares Outstanding | 159.8M | ||
Total Assets | $1.2B | ||
Market Cap | $3.3B | ||
Enterprise Value | $3.1B | ||
Period: QTR TTM FY | |||
Revenue | $3.6M | ||
Net Income | -$127.6M | ||
Free Cash Flow | -$97.8M | ||
EBIT | -$127.6M | ||
EBITDA | -$124.0M | ||
Net Working Capital | $663.8M | ||
EPS | -$0.68 | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | 855 | ||
P/B | 4 | ||
P/E | -30 | ||
PEG | -21 | ||
Price/Free Cash Flow | -34 | ||
Price/Operating Cash Flow | -34 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue